These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7842272)

  • 1. Hypertensive cardiovascular disease and the treatment of hypertension in the elderly.
    Pearce KA; Furberg CD
    Curr Opin Nephrol Hypertens; 1994 Mar; 3(2):213-7. PubMed ID: 7842272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
    Petrovitch H; Vogt TM; Berge KG
    Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.
    Furberg CD; Cutler JA
    Hypertension; 1989 May; 13(5 Suppl):I57-61. PubMed ID: 2577460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of treatment of the elderly hypertensive.
    Moser M
    Geriatrics; 1989 Oct; 44 Suppl B():30-6. PubMed ID: 2680778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the risk for coronary heart disease and stroke in hypertensives--comments on mechanisms for coronary protection and quality of life.
    Wikstrand J
    J Clin Pharm Ther; 1992 Feb; 17(1):9-29. PubMed ID: 1548319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled clinical trials of drug treatment for hypertension. A review.
    Cutler JA; MacMahon SW; Furberg CD
    Hypertension; 1989 May; 13(5 Suppl):I36-44. PubMed ID: 2490827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences from hypertension trials--effects on stroke and coronary heart disease.
    Berglund G
    Drugs; 1988; 36 Suppl 3():5-8. PubMed ID: 3076121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Office management of hypertension in older persons.
    Aronow WS
    Am J Med; 2011 Jun; 124(6):498-500. PubMed ID: 21605724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.
    Staessen JA; Fagard R; Thijs L; Celis H; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene MR; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A
    Arch Intern Med; 1998 Aug 10-24; 158(15):1681-91. PubMed ID: 9701103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
    Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD
    JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the elderly hypertensive patient beyond blood pressure reduction.
    Holzgreve H
    J Hypertens Suppl; 1995 Aug; 13(2):S103-7. PubMed ID: 8576779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy and the concept of total cardiovascular protection.
    Mason DT; Chan MC; Lee G
    Am J Cardiol; 1987 Sep; 60(9):29E-32E. PubMed ID: 2889351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.
    Collins R; Peto R; MacMahon S; Hebert P; Fiebach NH; Eberlein KA; Godwin J; Qizilbash N; Taylor JO; Hennekens CH
    Lancet; 1990 Apr; 335(8693):827-38. PubMed ID: 1969567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-hemodynamic vascular risk in the patient with arterial hypertension. The effects of medical therapy].
    Magnani B; Rapezzi C
    Cardiologia; 1994 Dec; 39(12 Suppl 1):299-302. PubMed ID: 7634287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.
    Messerli FH; Grossman E; Goldbourt U
    JAMA; 1998 Jun; 279(23):1903-7. PubMed ID: 9634263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.